Volume 15, Issue 4, Pages (April 2014)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 14, Issue 12, Pages (November 2013)

Volume 14, Issue 4, Pages (April 2013)

Volume 357, Issue 9273, Pages (June 2001)

Volume 17, Issue 12, Pages (December 2016)

Volume 367, Issue 9517, Pages (April 2006)

Pharmacogenetics and future drug development and delivery

Volume 12, Issue 11, Pages (October 2011)

Volume 17, Issue 8, Pages (August 2016)

Volume 15, Issue 1, Pages (January 2014)

Volume 16, Issue 9, Pages (September 2015)

Volume 15, Issue 6, Pages (May 2014)

Volume 378, Issue 9785, Pages (July 2011)

Volume 376, Issue 9734, Pages (July 2010)

Volume 17, Issue 2, Pages (February 2016)

Thank God for Richard Dawkins?

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 14, Issue 4, Pages (April 2013)

Volume 377, Issue 9783, Pages (June 2011)

Volume 373, Issue 9666, Pages (March 2009)

Volume 376, Issue 9734, Pages (July 2010)

Volume 366, Issue 9482, Pages (July 2005)

Volume 14, Issue 3, Pages (March 2013)

Volume 379, Issue 9823, Pages (April 2012)

Volume 17, Issue 8, Pages (August 2016)

Volume 12, Issue 9, Pages (September 2013)

Aspirin in the prevention of cancer – Author's reply

Volume 366, Issue 9482, Pages (July 2005)

Volume 15, Issue 4, Pages (April 2014)

Volume 15, Issue 1, Pages (January 2014)

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials David Moher, MSc, Kenneth F Schulz,

Volume 373, Issue 9663, Pages (February 2009)

Volume 378, Issue 9786, Pages (July 2011)

Volume 15, Issue 4, Pages (April 2014)

Volume 9, Issue 10, Pages (October 2008)

Volume 392, Issue 10141, Pages (July 2018)

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,

Volume 385, Issue 9969, Pages (February 2015)

Volume 18, Issue 3, Pages (March 2017)

Volume 15, Issue 1, Pages (January 2014)

Volume 378, Issue 9785, Pages (July 2011)

Volume 6, Issue 6, Pages (June 2005)

Volume 13, Issue 1, Pages (January 2012)

Volume 14, Issue 6, Pages (May 2013)

Volume 11, Issue 4, Pages (April 2010)

Volume 14, Issue 11, Pages (October 2013)

Volume 385, Issue 9962, Pages (January 2015)

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled,

Confessions of a journal junkie

Volume 371, Issue 9625, Pages (May 2008)

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 371, Issue 9627, Pages (May 2008)

Volume 18, Issue 8, Pages (August 2017)

Volume 9, Issue 4, Pages (April 2008)

Volume 381, Issue 9880, Pages (May 2013)

Volume 14, Issue 6, Pages (May 2013)

Volume 13, Issue 11, Pages (November 2012)

Volume 5, Issue 4, Pages (April 2018)

Thank God for Richard Dawkins?

Volume 375, Issue 9714, Pages (February 2010)

Volume 15, Issue 6, Pages (May 2014)

Volume 15, Issue 8, Pages (July 2014)

Volume 11, Issue 3, Pages (March 2010)

Volume 11, Issue 1, Pages (January 2010)

Volume 375, Issue 9715, Pages (February 2010)

Volume 14, Issue 9, Pages (August 2013)

Volume 13, Issue 7, Pages (July 2014)

Volume 372, Issue 9632, Pages (July 2008)

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Volume 17, Issue 2, Pages (February 2016)

Presentation transcript:

Volume 15, Issue 4, Pages 457-463 (April 2014) 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial Prof Peter J Hoskin, FRCR, Amy A Kirkwood, MSc, Bilyana Popova, MSc, Paul Smith, MSc, Martin Robinson, FRCR, Eve Gallop-Evans, FRCR, Stewart Coltart, FRCR, Prof Timothy Illidge, FRCR, Krishnaswamy Madhavan, FRCR, Caroline Brammer, FRCR, Patricia Diez, MSc, Prof Andrew Jack, FRCPath, Isabel Syndikus, FRCR The Lancet Oncology Volume 15, Issue 4, Pages 457-463 (April 2014) DOI: 10.1016/S1470-2045(14)70036-1 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile All numbers refer to randomised sites, not patients. *All radiotherapy target sites are included in the analysis of local progression (the primary endpoint). The Lancet Oncology 2014 15, 457-463DOI: (10.1016/S1470-2045(14)70036-1) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Progression-free survival for all sites (A) and overall survival for one site per patient (B) The Lancet Oncology 2014 15, 457-463DOI: (10.1016/S1470-2045(14)70036-1) Copyright © 2014 Elsevier Ltd Terms and Conditions